Arlington Capital Management »

Inovio Pharmaceuticals shares owned by Arlington Capital Management

Quarter-by-quarter ownership of Inovio Pharmaceuticals shares owned by Arlington Capital Management from 13F filings

Historical chart of Arlington Capital Management investment in Inovio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inovio Pharmaceuticals held by Arlington Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inovio Pharmaceuticals by Arlington Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $14k 28k 0.51
2023-09-30 $11k 28k 0.39
2023-06-30 $12k 28k 0.45
2023-03-31 $23k 28k 0.82
2022-12-31 $44k 28k 1.56

More positions owned by Arlington Capital Management

Ishares Gold Tr Ishares New (IAU)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Us Home Cons Etf (ITB)
NVIDIA Corporation (NVDA)
Barclays Bank Ipth Sr B S&p (VXX)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Tr Expanded Tech (IGV)
Select Sector Spdr Tr Technology (XLK)
Super Micro Computer (SMCI)
Proshares Tr Ultrashrt S&p500 (SDS)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Innovator Etfs Trust Invatr 20 Pls 9 (TBJL)
Microstrategy Cl A New (MSTR)
Acm Resh Com Cl A (ACMR)

View all positions for Arlington Capital Management

Top funds holding Inovio Pharmaceuticals

Vanguard Group
GSA Capital Partners
D. E. Shaw & Co
Jacobs Levy Equity Management
Jane Street
Millennium Management
Citadel Advisors
Bank of America Corporation
Two Sigma Investments
Hrt Financial
Amundi
Charles Schwab Investment Management
Prime Capital Investment Advisors
Keystone Financial Group
Two Sigma Advisers

View all funds holding Inovio Pharmaceuticals